First AD

Second AD

Anyone who has received two doses of mRNA vaccine

All patients with rheumatoid arthritis taking immunosuppressant treatments who received mRNA vaccine as their primary course

All patients with rheumatoid arthritis taking immunosuppressant treatments

At least 1 month after the first 2 mRNA doses

At least 2 months after the first 2 mRNA doses

At least 3 months after the first 2 mRNA doses

At least 4 months after the first 2 mRNA doses

At least 5 months after the first 2 mRNA doses

No second dose is required because J&J is a single dose vaccine

Patients who received the J&J vaccine should be given an mRNA vaccine as their second dose 

Patients should receive a booster dose at least two months after their primary vaccination

mRNA vaccines are preferred over J&J for immunocompromised people aged 18 years and older

Rheumatoid Arthritis Quizzes

News

news page, resources on the topics of disease- and specialty-specific medical news and expert insight can be found. Content includes articles, interviews, videos, podcasts, and breaking news on health care research, treatment, and drug development.

Rheumatology

Rheumatology condition center page is a comprehensive resource for clinical news and insights on rheumatologic disease. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for arthritis, gout, nr-AxSpA, and more.

The American College of Rheumatology has recently updated its recommendations on COVID-19 booster vaccines. Test your knowledge of the latest advice on COVID-19 boosters and how they should be administered with this quiz.

Rheumatoid Arthritis Quiz: COVID-19 Vaccine Booster